Food and Drug AdministrationImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to FDA main menu
DonateNow
Print this Article




Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection Update

Food and Drug Administration - December 1, 2004
Richard Klein

The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection have been updated.

The Pediatric Guidelines, developed by the Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, now include Supplement II, titled "Managing Complications of HIV Infection in HIV-Infected Children on Antiretroviral Therapy, "and Supplement III, titled "Adverse Drug Effects." Also included in the new version are updates to the atazanavir, indinavir, and enfuvirtide sections in Supplement I, "Pediatric Antiretroviral Drug Information."

All new information is highlighted in yellow in the main document. Supplements II and III are new to the guidelines and are highlighted in title only.

The updated guidelines document is available in the Pediatric Guidelines section at:
(http://aidsinfo.nih.gov/guidelines/default_db2.asp?id=51) of the Guidelines page on the AIDSinfo Web site.

Richard Klein HIV/AIDS Program Director Office of Special Health Issues Food and Drug Administration
041201
FD041203

SOURCE: Food and Drug Administration (FDA).

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .